A
Anhui Ronds Science & Technology Inc Co
SSE:688768
Anhui Ronds Science & Technology Inc Co
SSE:688768
Price:
45.61
CNY
5.55%
Market Closed
Market Cap:
¥4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Anhui Ronds Science & Technology Inc Co
SSE:688768
|
CN |
|
T
|
Tianda Pharmaceuticals Ltd
HKEX:455
|
HK |
Income Statement
Earnings Waterfall
Anhui Ronds Science & Technology Inc Co
Anhui Ronds Science & Technology Inc Co
Income Statement
Anhui Ronds Science & Technology Inc Co
Anhui Ronds Science & Technology Inc Co
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
1
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
|
| Revenue |
410
N/A
|
463
+13%
|
484
+4%
|
547
+13%
|
565
+3%
|
544
-4%
|
524
-4%
|
498
-5%
|
502
+1%
|
512
+2%
|
541
+6%
|
584
+8%
|
607
+4%
|
620
+2%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(165)
|
(187)
|
(196)
|
(196)
|
(207)
|
(197)
|
(192)
|
(189)
|
(196)
|
(201)
|
(213)
|
(212)
|
(226)
|
(229)
|
|
| Gross Profit |
246
N/A
|
277
+13%
|
287
+4%
|
351
+22%
|
357
+2%
|
347
-3%
|
332
-4%
|
309
-7%
|
305
-1%
|
311
+2%
|
328
+6%
|
371
+13%
|
381
+3%
|
392
+3%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(172)
|
(192)
|
(209)
|
(243)
|
(251)
|
(279)
|
(293)
|
(260)
|
(255)
|
(250)
|
(248)
|
(265)
|
(260)
|
(272)
|
|
| Selling, General & Administrative |
(133)
|
(144)
|
(155)
|
(176)
|
(178)
|
(192)
|
(198)
|
(179)
|
(175)
|
(172)
|
(176)
|
(189)
|
(187)
|
(196)
|
|
| Research & Development |
(62)
|
(70)
|
(81)
|
(89)
|
(104)
|
(117)
|
(126)
|
(105)
|
(107)
|
(104)
|
(99)
|
(102)
|
(106)
|
(110)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
|
| Other Operating Expenses |
24
|
23
|
27
|
29
|
32
|
31
|
31
|
33
|
27
|
26
|
27
|
34
|
33
|
34
|
|
| Operating Income |
73
N/A
|
85
+16%
|
78
-7%
|
108
+38%
|
106
-2%
|
68
-36%
|
39
-43%
|
49
+27%
|
51
+3%
|
61
+19%
|
80
+33%
|
106
+32%
|
121
+14%
|
120
-1%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
6
|
7
|
7
|
7
|
4
|
3
|
1
|
2
|
(1)
|
(0)
|
0
|
2
|
2
|
2
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Total Other Income |
10
|
14
|
13
|
9
|
4
|
2
|
2
|
3
|
3
|
2
|
1
|
2
|
2
|
2
|
|
| Pre-Tax Income |
89
N/A
|
105
+19%
|
99
-6%
|
124
+25%
|
115
-7%
|
73
-37%
|
42
-42%
|
52
+24%
|
53
+2%
|
62
+17%
|
82
+33%
|
109
+34%
|
124
+14%
|
123
-1%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
(7)
|
(9)
|
(4)
|
(8)
|
(5)
|
9
|
13
|
11
|
10
|
3
|
(0)
|
(2)
|
(4)
|
(2)
|
|
| Income from Continuing Operations |
82
|
96
|
95
|
116
|
110
|
82
|
55
|
63
|
63
|
65
|
82
|
108
|
120
|
121
|
|
| Net Income (Common) |
82
N/A
|
96
+18%
|
95
-2%
|
116
+22%
|
110
-5%
|
82
-26%
|
55
-33%
|
63
+14%
|
63
+1%
|
65
+2%
|
82
+27%
|
108
+31%
|
120
+12%
|
121
+1%
|
|
| EPS (Diluted) |
1.49
N/A
|
1.75
+17%
|
1.16
-34%
|
1.43
+23%
|
1.35
-6%
|
1.01
-25%
|
0.68
-33%
|
0.77
+13%
|
0.77
N/A
|
0.79
+3%
|
1
+27%
|
1.3
+30%
|
1.37
+5%
|
1.38
+1%
|
|
Switch to:
Switch to:
See Also
Discover More
